Erythromycin targets the 50S ribosomal subunit of bacteria. Specifically, it binds to the 23S rRNA within the peptidyl transferase center (PTC).
This binding site is crucial for peptide bond formation during protein synthesis. Erythromycin’s presence physically obstructs this process.
The precise interaction involves hydrogen bonding and hydrophobic interactions between the macrolide ring of erythromycin and specific nucleotide bases and sugar moieties in the rRNA.
This steric hindrance prevents the tRNA molecules from binding correctly and moving through the ribosome, effectively halting protein synthesis.
The result is a disruption of bacterial protein production, leading to bacterial cell death. Different bacterial species may exhibit varying degrees of sensitivity depending on their ribosomal structures.
Research continues to refine our understanding of the precise molecular interactions, offering insights into developing new antibiotics with improved efficacy and reduced resistance.
